Side-by-side comparison of AI visibility scores, market position, and capabilities
Santa Rosa electronic test and measurement (NYSE: KEYS) at ~$5B revenue; record Q4 with 14% order growth driven by AI datacenter testing and 6G research, Spirent $1.5B acquisition (2024) competing with Rohde & Schwarz.
Keysight Technologies, Inc. is a Santa Rosa, California-based electronic design, test, and measurement solutions company — publicly traded on the New York Stock Exchange (NYSE: KEYS) as an S&P 500 Information Technology component — providing hardware instruments, software platforms, and services for designing, testing, and validating electronic systems across 5G/6G wireless, AI data center infrastructure, aerospace and defense, automotive, and quantum computing through approximately 15,500 employees with approximately $5 billion in annual revenue. Keysight's heritage traces to Hewlett-Packard's test and measurement division (founded 1939), which became Agilent Technologies in 1999 and spun off Keysight as an independent company in 2014. In its most recent fiscal quarter, Keysight reported 14% order growth, 10% revenue growth to $1.42 billion, and 16% higher adjusted EPS — its best quarterly performance in two years — driven by demand for AI data center testing, early 6G wireless infrastructure research, and defense electronics modernization, alongside contributions from three major acquisitions completed in October 2024. The company's key acquisitions include Spirent Communications ($1.5 billion, 2024, network test and cybersecurity validation), ESI Group ($1 billion, 2023, electromagnetic simulation), and Ixia ($1.6 billion, 2017, network testing). Keysight's PathWave software platform integrates design simulation, test automation, and analytics workflows into a unified environment that semiconductor and wireless chipset teams use to accelerate development cycles from simulation to hardware validation.
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.